After the isoxazoline gold rush: Where will industry turn for next big antiparasitic windfall?

摘要

The antiparasitic space has been an active battleground for the animal health industry for many decades. It is the largest single product market in animal health and will undoubtedly remain a key growth driver over the coming years. Animal Pharm editor Joseph Harvey canvassed opinion from a range of thought leaders on opportunities and challenges in this key blockbuster market. Simparica Trio provides tick killing activity for five weeks against Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus and for four weeks against Dermacentor reticulatus. For fleas (Ctenocephalides felis and Ctenocephalides canis) it is effective for five weeks, while the product can also be used as part of a treatment strategy for the control of flea allergy dermatitis.